Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Pro-2-Cool Pivotal Trial II

NCT: NCT06929923 · RECRUITING

NCT IDNCT06929923
StatusRECRUITING
Start Date2025-02-20
Completion2027-06
SponsorTecTraum Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

This study is being conducted to determine the clinical safety and efficacy of Pro-2-Cool mediated head and neck cooling when applied after concussion and improved symptomatology among adolescent athletes as quantified by post-concussion symptom severity (PCSS) score.

Frequently Asked Questions

What is Pro-2-Cool Pivotal Trial II?

Pro-2-Cool Pivotal Trial II is a clinical trial registered under NCT06929923. Current status: RECRUITING.

What is the status of NCT06929923?

The current status of NCT06929923 (Pro-2-Cool Pivotal Trial II) is: RECRUITING.

When did Pro-2-Cool Pivotal Trial II start?

Pro-2-Cool Pivotal Trial II started on 2025-02-20.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.